You are here

  • Home
  • Archive
  • Volume 28, Issue Suppl 1
  • 4CPS-318 Compounding tacrolimus ophthalmic ointment 0.02% in the treatment of inflammatory and autoimmune ophthalmic syndromes: effectiveness and safety assessment

Article metrics

Article menu

Download PDFPDF

Section 4: Clinical pharmacy services
4CPS-318 Compounding tacrolimus ophthalmic ointment 0.02% in the treatment of inflammatory and autoimmune ophthalmic syndromes: effectiveness and safety assessment
Free

 

Online download statistics by month:

Online download statistics by month: March 2021 to August 2024

AbstractFullPdf
Mar 202131011
Apr 20215609
May 2021004
Jun 2021001
Jul 2021001
Aug 20210015
Sep 2021002
Oct 202117026
Nov 20217012
Dec 20211404
Jan 2022601
Feb 20221400
Mar 2022702
Apr 20221402
May 20222006
Jun 20221204
Jul 20222200
Aug 2022405
Sep 20223209
Oct 20221403
Nov 20221402
Dec 20221405
Jan 20232309
Feb 2023400
Mar 20233402
Apr 20232003
May 20231501
Jun 2023600
Jul 20231204
Aug 2023801
Sep 20231003
Oct 20231201
Nov 20232105
Dec 20231901
Jan 20241303
Feb 2024601
Mar 202414013
Apr 20241803
May 20242104
Jun 2024502
Jul 2024803
Aug 20241505
Total5820188